| Document |
Document Title |
|
WO/2009/052350A1 |
The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, Y, R1 R2, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula I are useful for the treatment of d...
|
|
WO/2009/052334A1 |
The present invention relates to compounds of Formula (I) as shown below, wherein the definitions of A, X, R1, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula (I) are useful for the treatment of dis...
|
|
WO/2009/048553A2 |
A process for the ammoxidation or oxidation of a saturated or unsaturated or mixture of saturated and unsaturated hydrocarbon, the process including the steps of combining a performance modifier, a fresh mixed oxide catalyst, or a used m...
|
|
WO/2009/047905A1 |
Disclosed is a selective ester production process of an alcoholic hydroxyl group, which proceeds under chemically mild conditions, while having adequate environmental suitability, operability and economical efficiency. Specifically discl...
|
|
WO/2009/047408A1 |
The invention relates to a method for the continuous crystallisation of a mixture of stereo-isomers and a resolution agent in a solvent, said mixture and resolution agent being injected into a continuously stirred reactor and the crystal...
|
|
WO/2009/043784A1 |
Compounds of the formula (I) wherein Ar1, Ar2, R1 and R2 are as defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the subject compounds.
|
|
WO/2009/044081A1 |
The subject of the present invention is a process for preparing acrolein by dehydration of glycerol in the presence of a catalyst system based on iron phosphorus oxide containing, in addition, one or more elements chosen from alkali meta...
|
|
WO/2009/036908A1 |
The present invention relates to novel imidazoline derivatives and their use as insecticidal, molluscicidal and nematocidal agents. The invention also extends to insecticidal, molluscicidal and nematicidal compositions comprising such im...
|
|
WO/2009/036909A1 |
The present invention relates to novel imidazoline derivatives and their use as insecticidal, acaricidal, molluscicidal and nematocidal agents. The invention also extends to insecticidal, acaricidal, molluscicidal and nematicidal composi...
|
|
WO/2009/034258A1 |
The invention relates to tri-amino-pyrimidine derivatives of the general formula (I) in which Y, R3, W, R4a, R5a, R4b, R5b, n and m are variable. These compounds have a phosphatase CDC25 inhibiting activity and can thus be used as drugs ...
|
|
WO/2009/033488A1 |
This patent discloses a method for resolution of 4-[4-(dimethylamino)-1-(4´-fluorophenyl)-1-hydroxybutyl]-3-
(hydroxymethyl)-benzonitrile as a racemic or non-racemic enantiomer mixture into its isolated enantiomers, said method comprisi...
|
|
WO/2009/034936A1 |
Disclosed is a method for producing N-methacryloyl-4-cyano-3-trifluoromethylaniline, wherein 4-cyano-3-trifluoromethylaniline is crystallized from a solvent mixture of methanol and water, and the thus-obtained 4-cyano-3-trifluoromethylan...
|
|
WO/2009/030457A1 |
The invention relates to methods of using certain compounds of formula (I), (II) and (III) in the synthesis of an insecticide intermediate of formula (IV), wherein the substituents are as defined in claim 1, to processes for preparing th...
|
|
WO/2009/028608A1 |
[PROBLEMS] To provide a process for producing 2-iodophenol derivatives or 2,6-diiodophenol derivatives by iodinating phenol derivatives at ortho position which can dispense the recovery of iodine and makes it possible to produce the obje...
|
|
WO/2009/026091A1 |
There are disclosed high yield and high productivity processes for preparing 3-hydroxyglutaronitrile by reacting allyl cyanide epoxide with a basic aqueous solution of a cyanide source.
|
|
WO/2009/025160A1 |
A transition metal complex which is obtained by bringing a bipyridine compound represented by the formula (1): (1) (wherein R1, R2, and R3 each represents optionally substituted C1-10 alkyl, etc.; and R4 and R5 each represents hydrogen, ...
|
|
WO/2009/023964A1 |
The present invention relates to biphenyl compounds of formula (I). These compounds are renin inhibitors of a non- peptidic nature and of low molecular weight. The invention further relates to a pharmaceutical composition containing said...
|
|
WO/2009/021751A1 |
The present invention relates to an industrially practicable process for preparing alkali metal and alkaline earth metal tricyanomethanides in a particularly high purity.
|
|
WO/2009/020676A1 |
The photostabilizing electronic excited state energy - particularly singlet state energy from a UV-absorbing molecule has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds of formulas (I) and (V) ha...
|
|
WO/2009/020674A1 |
Disclosed herein are compounds of formula (I), compositions having compounds of formula (I) and methods of stabilizing a photodegradable polymer or compound in a composition; wherein R1, R2, and R3 are the same or different and are selec...
|
|
WO/2009/018740A1 |
Disclosed are formular (I) compounds, or its stereo chemical isomers, or their mixture, the preparation of the compound and use in preparation of insecticide, in which, X represents halogen atom, i.e. F, Cl or Br. The insecticide can be ...
|
|
WO/2009/020675A1 |
The photostabilizing electronic excited state energy - particularly singlet state energy from a UV-absorbing molecule has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds of formulas (I) and (V) ha...
|
|
WO/2009/017798A1 |
Disclosed are new conjugated compounds (e.g., monomers and polymers) that include ladder-type moieties which can be used for preparing semiconducting materials. Such conjugated compounds can exhibit high n-type carrier mobility and/or go...
|
|
WO/2009/012954A1 |
The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt, wherein W, X, Y, Z, R1, R...
|
|
WO/2009/013199A2 |
The present invention relates to a process for the preparation of ethylgeranonitrile (3,7-dimethyl-2,6-nonadienenitrile) by converting ethylheptenone with a deprotonated nitrile (acetonitrile, cyanoacetic acid or cyanoacetic acid ester) ...
|
|
WO/2008/145941A9 |
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...
|
|
WO/2009/010156A2 |
The invention relates to compounds of formula (I) or the salts thereof, wherein Q is a (hetero)aromatic radical having up to 6 ring atoms, the ring of the heteroaromatic radical comprising 1, 2, 3 or 4 nitrogen atoms or 1 sulphur atom or...
|
|
WO/2009/010991A2 |
The present invention relates to an industrially advantageous method for the purification of anastrozole of Formula (I), wherein isoanastrozole of Formula (VI), present in crude anastrozole as an impurity, is removed by using gel purific...
|
|
WO/2009/010947A1 |
The present invention is directed to compounds having strong 2-photon absorbance for the manufacture of polymers suitable for various electro-optic applications.
|
|
WO/2009/011327A1 |
Disclosed is an organic electroluminescent device material containing an indenofluorenedione derivative represented by the following formula (I). (In the formula, X1 and X2 may be the same or different and each represents a specific diva...
|
|
WO/2009/007396A1 |
The present invention relates to nonsteroidal progesterone receptor modulators of the general formula (I), to the use of the progesterone receptor modulators for the preparation of medicaments, and to pharmaceutical compositions which co...
|
|
WO/2009/004990A1 |
It is intended to provide a prostaglandin F2α receptor agonist (FP receptor agonist), which comprises a biphenyl derivative represented by the following general formula (I) (wherein m represents an integer of 0 to 2; n represents an int...
|
|
WO/2009/003589A1 |
The present invention relates to a process for the regioselective synthesis of compounds of the formula (I), wherein R1; R2; R3; R4; R5; J and W have the meanings indicated in the claims. The present invention provides an efficient and g...
|
|
WO/2009/006061A2 |
Disclosed is a method for preparing a compound of Formula 1 comprising (1) contacting a compound of Formula 2, with (2) at least one alkali metal cyanide and (3) at least one compound of Formula (4); wherein R1 is NHR3 or OR4; R2 is CH3 ...
|
|
WO/2009/000663A1 |
Compounds of formula (I), wherein R 1, R 2 , R 3, X and Ar, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and ...
|
|
WO/2009/001372A2 |
The present invention encompasses novel intermediates of pregabalin, namely 3 -cyano-5 -methyl hexanamide (28) and 3-(amino methyl)-5 methyl hexanamide (29), and processes for their preparation. The invention also encompasses a process f...
|
|
WO/2009/001819A1 |
Disclosed is a method for producing a fluoroamide represented by the following formula (2): CF2=CF-Rf-CONH2 (wherein Rf is as defined below), wherein a fluoroester represented by the following formula (1): CF2=CF-Rf-COOR (wherein Rf repr...
|
|
WO/2008/157218A1 |
A process and apparatus for reacting deleterious impurities contained in adiponitrile (ADN) comprises feeding ADN and an ozone containing gas into a co-current plug flow reactor containing static mixer elements, to oxidize at least a por...
|
|
WO/2008/155619A2 |
Methods and materials for preparing an optically active compound of Formula (1), or a pharmaceutically acceptable salt thereof, or an opposite enantiomer of the compound of Formula (1) or pharmaceutically acceptable salt thereof, are dis...
|
|
WO/2008/155613A1 |
A process for the preparation of famciclovir a compound of Formula (I) and its intermediates.
|
|
WO/2008/153159A1 |
It is intended to provide a novel amine compound represented by the following general formula (I), a pharmaceutically acceptable acid addition salt thereof, a hydrate thereof or a solvate thereof, which has an excellent peripheral blood ...
|
|
WO/2008/145940A2 |
The invention relates to a joint method of producing fatty nitriles and/or amines and dialkyl carbonates of formula R1O-CO-OR1 in which R1 comprises from 1 to 4 carbon atoms, starting from an ester of a saturated or unsaturated fatty aci...
|
|
WO/2008/144275A1 |
The present invention relates to novel aryloazol-2-yl-cyanoethylamino derivatives of formula (I):wherein R3, R4, R5, R6, R7, P, Q, V, W, X, Y, Z and a are as defined in the description, compositions thereof, processes for their preparati...
|
|
WO/2008/138812A2 |
The present invention relates to pyridinone based azo dyes and/or of anionic azo metal complex dye salts made thereof with cationic basic yellow dyes, which are characterized by an unsaturated bond in beta-position to the endocyclic N at...
|
|
WO/2008/138639A1 |
This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper- proliferative and/or angiogenesis disorde...
|
|
WO/2008/136492A1 |
A polymer comprising a structural unit represented by the formula (1) and repeating units represented by any of the formulae (2) to (4). (In the formula, x3, y1, y2, and z1 to z3 each is 0 or 1; y3 is an integer of 0-2; u is an integer o...
|
|
WO2008087656B1 |
A process for the preparation of unsymmetrical biaryl compounds of Formula (I) wherein, R is alkyl, R' is cyano, protected or unprotected tetrazole, or Formula (a) wherein, R" is alkyl, aryl, aralkyl or alkoxy, said process comprising, r...
|
|
WO/2008/132103A1 |
The invention relates to pentaphenylene derivatives of the general formulas (I), (II), (III), and (IV), in which D represents a group of formula (y1) or a group of formula (y2) or hydrogen, wherein R, R' and R'' represent an alkyl group,...
|
|
WO/2008/126770A1 |
It is intended to provide a highly safe and novel therapeutic or preventive agent for hyperuricemia, gout, an inflammatory bowel disease, diabetic nephropathy, diabetic retinitis or the like based on an excellent xanthine oxidase inhibit...
|
|
WO/2008/125994A1 |
The present invention relates to the field of perfumery. More particularly, it concerns specific oxime or nitrile derivatives of 4-dodecene, which are useful perfuming ingredients in particular to impart natural mandarin notes.
|
